DZ Bank’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.43B Sell
2,914,918
-616,675
-17% -$335M 1.27% 17
2025
Q4
$2.05B Buy
3,531,593
+1,027,509
+41% +$581M 1.77% 9
2025
Q3
$1.21B Buy
2,504,084
+1,970,033
+369% +$917M 1.06% 24
2025
Q2
$217M Sell
534,051
-1,589,589
-75% -$665M 0.22% 93
2025
Q1
$1.06B Buy
2,123,640
+588,497
+38% +$319M 1.18% 18
2024
Q4
$799M Sell
1,535,143
-159,095
-9% -$87.5M 0.81% 32
2024
Q3
$1.05B Sell
1,694,238
-466,518
-22% -$276M 1.03% 27
2024
Q2
$1.19B Sell
2,160,756
-27,824
-1% -$15.9M 1.22% 16
2024
Q1
$1.27B Buy
2,188,580
+543,918
+33% +$305M 1.36% 16
2023
Q4
$873M Sell
1,644,662
-865,916
-34% -$419M 1.09% 24
2023
Q3
$1.27B Buy
2,510,578
+1,417,175
+130% +$755M 1.81% 12
2023
Q2
$570M Sell
1,093,403
-777,769
-42% -$420M 0.86% 28
2023
Q1
$1.08B Sell
1,871,172
-31,313
-2% -$17.6M 1.77% 9
2022
Q4
$1.05B Sell
1,902,485
-101,409
-5% -$53.7M 1.82% 11
2022
Q3
$1.02B Sell
2,003,894
-16,232
-0.8% -$9.08M 1.92% 9
2022
Q2
$1.1B Buy
2,020,126
+1,263,441
+167% +$695M 1.98% 7
2022
Q1
$447M Sell
756,685
-95,404
-11% -$54.8M 0.67% 44
2021
Q4
$567M Sell
852,089
-40,130
-4% -$25.1M 0.8% 40
2021
Q3
$510M Buy
892,219
+22,447
+3% +$12.3M 0.81% 38
2021
Q2
$439M Sell
869,772
-14,674
-2% -$6.92M 0.71% 43
2021
Q1
$404M Sell
884,446
-387,174
-30% -$185M 0.74% 39
2020
Q4
$587M Sell
1,271,620
-545,737
-30% -$256M 1.24% 17
2020
Q3
$802M Buy
1,817,357
+302,047
+20% +$125M 1.92% 9
2020
Q2
$549M Buy
1,515,310
+323,986
+27% +$109M 1.51% 12
2020
Q1
$338M Sell
1,191,324
-91,943
-7% -$29M 1.14% 18
2019
Q4
$417M Buy
1,283,267
+48,810
+4% +$14.8M 1.09% 21
2019
Q3
$360M Sell
1,234,457
-106,204
-8% -$30.4M 1.07% 20
2019
Q2
$394M Sell
1,340,661
-406,862
-23% -$112M 1.22% 19
2019
Q1
$478M Buy
1,747,523
+104,753
+6% +$26.1M 1.55% 14
2018
Q4
$365M Sell
1,642,770
-250,762
-13% -$58.8M 1.42% 15
2018
Q3
$462M Buy
1,893,532
+19,986
+1% +$4.6M 1.64% 8
2018
Q2
$388M Buy
1,873,546
+71,666
+4% +$15.2M 1.43% 10
2018
Q1
$365M Sell
1,801,880
-38,470
-2% -$8.07M 1.41% 10
2017
Q4
$349M Buy
1,840,350
+193,523
+12% +$37.1M 1.34% 14
2017
Q3
$312M Buy
1,646,827
+594,069
+56% +$108M 1.29% 15
2017
Q2
$184M Buy
1,052,758
+9,524
+0.9% +$1.6M 0.85% 36
2017
Q1
$160M Buy
1,043,234
+283,163
+37% +$43.3M 0.73% 44
2016
Q4
$107M Buy
+760,071
New +$112M 0.52% 58

Other funds holding TMO

DZ Bank's TMO Position: Q1 2026 in Review

DZ Bank reduced its Thermo Fisher Scientific (TMO) stake by 17% in Q1 2026, selling an estimated $335M and leaving 2,914,918 shares worth $1.43B. The position accounts for 1.27% of the portfolio, ranked #17.

DZ Bank first reported a position in TMO in Q4 2016 and has held it in 38 quarters since. The position peaked at $2.05B in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • DZ Bank held 2,914,918 shares of Thermo Fisher Scientific worth $1.43B as of Q1 2026.
  • DZ Bank sold 616,675 Thermo Fisher Scientific shares in Q1 2026, an estimated $335M.
  • Thermo Fisher Scientific made up 1.27% of DZ Bank's portfolio in Q1 2026, its #17 holding.
  • DZ Bank first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 38 quarters since.
  • DZ Bank's Thermo Fisher Scientific position peaked at $2.05B in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.